Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 8 upcoming openings for the January – June 2018 co-op period.  We will be accepting applications starting in September 2017 via NUcareers.

CaNCURE Co-op Showcase

The CaNCURE Team would like to send out a congratulations to the 7 trainees who completed their CaNCURE co-op this June! We were so proud to see all your accomplishments at our third annual CaNCURE Nanomedicine Day and to learn that for many of you, this co-op was a career-defining experience!




Upcoming Events

Synergistic Antibacterial Mechanism of Combined Silver Nanoparticles and Conventional Antibiotics

Thursday, October 19, 2017

A combination of silver nanoparticles (AgNPs) and an antibiotic can synergistically inhibit bacterial growth, especially against the drug-resistant bacteria Salmonella typhimurium. However, the mechanism for the synergistic activity is not known. This study chooses four classes of antibiotics, β-lactam (ampicillin and penicillin), quinolone (enoxacin), aminoglycoside (kanamycin and neomycin), and polykeptide (tetracycline) to explore their synergistic […]

125 Snell Library -- NEU, 2:50 PM

Mentor Spotlight

William S Hancock, Ph.D.

Professor of Chemistry, NEU

Our lab is focused on advanced protein characterization methods for the study of cancer mechanisms and discovery of potential therapeutic agents. Students will use a nanoLC/MS coupled to a LTQ-Orbitrap to identify glycoprotein biomarkers and protein therapeutics.

Robert N Hanson, Ph.D.

Matthews Distinguished University Professor, NEU

Our lab develops targeting strategies for highly specific delivery of nanoparticle- and molecule-based therapeutics to breast and prostate cancer. Students will study the selectivity of self-assembled polymeric nanoparticles to tumor cells by using a multimeric peptidomimetic nanoplatform comprised of tumor cell-specific amino acids.

Trainee Spotlight

Victoria Dagostino

Bioengineering, '19

Development of a Point of Care Assay for Detecting High Risk HPV in Resource Limited Settings

Vivian Cheng

Health Science, '18

Delivery of Titanium Dioxide Nanoparticles via Biodegradable PLGA Dissolving Microneedles for Sustainable Release

Christina Flavin

Mechanical Engineering, '20

Assessment of Atherosclerotic Changes using Ferumoxytol as MRI Contrast Agent

Going on in the lab right now...